Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
内皮细胞衍生的血管生成素-2是治疗初治和贝伐珠单抗耐药性胶质母细胞瘤的治疗靶点
期刊:EMBO Molecular Medicine
影响因子:9
doi:10.15252/emmm.201505505
Alexander Scholz ,Patrick N Harter ,Sebastian Cremer ,Burak H Yalcin ,Stefanie Gurnik ,Maiko Yamaji ,Mariangela Di Tacchio ,Kathleen Sommer ,Peter Baumgarten ,Oliver Bähr ,Joachim P Steinbach ,Jörg Trojan ,Martin Glas ,Ulrich Herrlinger ,Dietmar Krex ,Matthias Meinhardt ,Astrid Weyerbrock ,Marco Timmer ,Roland Goldbrunner ,Martina Deckert ,Christian Braun ,Jens Schittenhelm ,Jochen T Frueh ,Evelyn Ullrich ,Michel Mittelbronn ,Karl H Plate ,Yvonne Reiss